Journal of magnetic resonance imaging : JMRI
-
J Magn Reson Imaging · Feb 2010
Randomized Controlled Trial Multicenter Study Comparative StudyComparison of gadodiamide-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of renal artery stenosis: results of a phase III multicenter trial.
To evaluate the efficacy and safety of 0.1 mmol/kg gadodiamide administration for contrast-enhanced magnetic resonance angiography (MRA) in detecting hemodynamically relevant renal artery stenosis (RAS) when compared with intraarterial digital subtraction angiography (IA-DSA) as the gold standard. ⋯ Gadodiamide administration at the labeled dose of 0.1 mmol/kg for contrast-enhanced MRA achieved equivalent results compared to IA-DSA in evaluation of RAS and was well tolerated.
-
J Magn Reson Imaging · Feb 2010
Randomized Controlled Trial Multicenter Study Comparative StudyEnhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
To compare enhancement of liver parenchyma in MR imaging after injection of hepatocyte-specific contrast media. ⋯ In the delayed, hepatocyte-specific phase, liver enhancement after injection of gadoxetic acid was superior to that obtained with gadobenate dimeglumine.